| 1 | [SID26660322] | Active | Potency | 0.5212 | qHTS of small molecules that selectively kill Giardia lamblia: Hit Validation in HepG2 cytotox [AID588382, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | Potency | 0.5212 [uM] | | BioAssay | qHTS of small molecules that selectively kill Giardia lamblia: Hit Validation in HepG2 cytotox | | AID | 588382 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID26660322] | Active | Potency | 0.8913 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | Potency | 0.8913 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 3 | [SID26660322] | Active | Potency | 1.7783 | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Mammalian cellular toxicity [AID2786, Type: confirmatory] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | Potency | 1.7783 [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Mammalian cellular toxicity | | AID | 2786 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID26660322] | Active | Potency | 4.0995 | qHTS of small molecules that selectively kill Giardia lamblia: Hit Validation. [AID588397, Type: confirmatory] | |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | Potency | 4.0995 [uM] | | BioAssay | qHTS of small molecules that selectively kill Giardia lamblia: Hit Validation. | | AID | 588397 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 5 | [SID26660322] | Active | Potency | 6.012 | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) [AID588342, Type: confirmatory] | Luciferase [Photinus pyralis] [gi:160794] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | Potency | 6.012 [uM] | | BioAssay | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) | | AID | 588342 | | BioAssay type | confirmatory | | Target | Luciferase [Photinus pyralis] [gi:160794] | | PubMed | | | Data Table |  |
|
| 6 | [SID26660322] | Active | Potency | 8.9125 | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Giardia lamblia growth inhibition [AID2785, Type: confirmatory] | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Giardia lamblia growth inhibition | | AID | 2785 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] | | PubMed | | | Data Table |  |
|
| 7 | [SID26660322] | Active | Potency | 11.5821 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | Potency | 11.5821 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID26660322] | Active | Potency | 12.9953 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | Potency | 12.9953 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 9 | [SID26660322] | Active | Potency | 15.8114 | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia [AID2451, Type: confirmatory] | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | Potency | 15.8114 [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia | | AID | 2451 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] | | PubMed | | | Data Table |  |
|
| 10 | [SID26660322] | Active | Potency | 23.1093 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line [AID686971, Type: confirmatory] | |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | Potency | 23.1093 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line | | AID | 686971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 11 | [SID26660322] | Active | Potency | 23.1093 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | Potency | 23.1093 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 12 | [SID26660322] | Active | Potency | 25.1189 | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) [AID2147, Type: confirmatory] | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) | | AID | 2147 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] | | PubMed | | | Data Table |  |
|
| 13 | [SID26660322] | Active | Potency | 39.8107 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 14 | [SID26660322] | Active | Potency | 44.6684 | HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails [AID540317, Type: confirmatory] | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | Potency | 44.6684 [uM] | | BioAssay | HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails | | AID | 540317 | | BioAssay type | confirmatory | | Target | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] | | PubMed | | | Data Table |  |
|
| 15 | [SID26660322] | Active | | | Primary Cell-based High Throughput Screening Assay for Inhibitors of Wee1 Degradation [AID1321, Type: screening] | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | BioAssay | Primary Cell-based High Throughput Screening Assay for Inhibitors of Wee1 Degradation | | AID | 1321 | | BioAssay type | screening | | Target | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] | | PubMed | | | Data Table |  |
|
| 16 | [SID26660322] | Active | | | Primary Cell-based High Throughput Screening Assay for Inhibitors of Wee1 Degradation [AID1321, Type: screening] | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | BioAssay | Primary Cell-based High Throughput Screening Assay for Inhibitors of Wee1 Degradation | | AID | 1321 | | BioAssay type | screening | | Target | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] | | PubMed | | | Data Table |  |
|
| 17 | [SID26660322] | Active | | | Primary Cell-based High Throughput Screening Assay for Inhibitors of Wee1 Degradation [AID1321, Type: screening] | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | BioAssay | Primary Cell-based High Throughput Screening Assay for Inhibitors of Wee1 Degradation | | AID | 1321 | | BioAssay type | screening | | Target | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] | | PubMed | | | Data Table |  |
|
| 18 | [SID26660322] | Active | | | uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay [AID624354, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | BioAssay | uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay | | AID | 624354 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 19 | [SID26660322] | Active | | | uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay [AID624354, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | BioAssay | uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay | | AID | 624354 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 20 | [SID26660322] | Active | | | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay [AID651596, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | BioAssay | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay | | AID | 651596 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 21 | [SID26660322] | Active | | | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay [AID651596, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | BioAssay | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay | | AID | 651596 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 22 | [SID26660322] | Active | | | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay [AID651596_1, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | BioAssay | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay | | AID | 651596 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 23 | [SID26660322] | Active | | | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay [AID651596_1, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | BioAssay | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay | | AID | 651596 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 24 | [SID26660322] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) [AID588852, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) | | AID | 588852 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 25 | [SID26660322] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) [AID588852, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) | | AID | 588852 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 26 | [SID26660322] | Active | | | uHTS of Mcl-1/Noxa interaction inhibitors [AID1022, Type: screening] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | BioAssay | uHTS of Mcl-1/Noxa interaction inhibitors | | AID | 1022 | | BioAssay type | screening | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 27 | [SID26660322] | Active | | | uHTS of Mcl-1/Noxa interaction inhibitors [AID1022, Type: screening] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | BioAssay | uHTS of Mcl-1/Noxa interaction inhibitors | | AID | 1022 | | BioAssay type | screening | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 28 | [SID26660322] | Active | | | uHTS of Mcl-1/Noxa interaction inhibitors [AID1022, Type: screening] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | BioAssay | uHTS of Mcl-1/Noxa interaction inhibitors | | AID | 1022 | | BioAssay type | screening | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 29 | [SID26660322] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 30 | [SID26660322] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 31 | [SID26660322] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 32 | [SID26660322] | Active | | | Primary cell-based high throughput assay for inhibitors of the Janus kinase 2 mutant JAK2V617F [AID1446, Type: screening] | Janus kinase 2 (a protein tyrosine kinase) [Homo sapiens] [gi:119579178] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | BioAssay | Primary cell-based high throughput assay for inhibitors of the Janus kinase 2 mutant JAK2V617F | | AID | 1446 | | BioAssay type | screening | | Target | Janus kinase 2 (a protein tyrosine kinase) [Homo sapiens] [gi:119579178] | | PubMed | | | Data Table |  |
|
| 33 | [SID26660322] | Active | | | Primary cell-based high throughput assay for inhibitors of the Janus kinase 2 mutant JAK2V617F [AID1446, Type: screening] | Janus kinase 2 (a protein tyrosine kinase) [Homo sapiens] [gi:119579178] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | BioAssay | Primary cell-based high throughput assay for inhibitors of the Janus kinase 2 mutant JAK2V617F | | AID | 1446 | | BioAssay type | screening | | Target | Janus kinase 2 (a protein tyrosine kinase) [Homo sapiens] [gi:119579178] | | PubMed | | | Data Table |  |
|
| 34 | [SID26660322] | Active | | | Primary cell-based high throughput assay for inhibitors of the Janus kinase 2 mutant JAK2V617F [AID1446, Type: screening] | Janus kinase 2 (a protein tyrosine kinase) [Homo sapiens] [gi:119579178] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | BioAssay | Primary cell-based high throughput assay for inhibitors of the Janus kinase 2 mutant JAK2V617F | | AID | 1446 | | BioAssay type | screening | | Target | Janus kinase 2 (a protein tyrosine kinase) [Homo sapiens] [gi:119579178] | | PubMed | | | Data Table |  |
|
| 35 | [SID26660322] | Active | | | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin [AID2314, Type: screening] | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | BioAssay | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin | | AID | 2314 | | BioAssay type | screening | | Target | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] | | PubMed | | | Data Table |  |
|
| 36 | [SID26660322] | Active | | | MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators [AID1814, Type: screening] | |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | BioAssay | MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators | | AID | 1814 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 37 | [SID26660322] | Active | | | Luminescence-based counterscreen assay for KLF5 inhibitors: cell-based high throughput screening assay to identify cytotoxic compounds using the IEC-6 intestinal epithelial cell line. [AID1825, Type: screening] | |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | BioAssay | Luminescence-based counterscreen assay for KLF5 inhibitors: cell-based high throughput screening assay to identify cytotoxic compounds using the IEC-6 intestinal epithelial cell line. | | AID | 1825 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 38 | [SID26660322] | Active | | | Counterscreen for inhibitors of Janus kinase 2 mutant JAK2V617F: Cell-based high throughput assay to identify inhibitors of parental Ba/F3 cell viability. [AID1486, Type: screening] | |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of Janus kinase 2 mutant JAK2V617F: Cell-based high throughput assay to identify inhibitors of parental Ba/F3 cell viability. | | AID | 1486 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 39 | [SID26660322] | Active | | | Identification of compounds which are cytotoxic to PPC-1 cells. [AID1447, Type: screening] | |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | BioAssay | Identification of compounds which are cytotoxic to PPC-1 cells. | | AID | 1447 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 40 | [SID26660322] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624040, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624040 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 41 | [SID26660322] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624040, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624040 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 42 | [SID26660322] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624040, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624040 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 43 | [SID26660322] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624040, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624040 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 44 | [SID26660322] | Active | | | uHTS for the identification of compounds that potentiate TRAIL-induced apoptosis of cancer cells [AID1443, Type: screening] | tumor necrosis factor ligand superfamily member 10 isoform 1 [Homo sapiens] [gi:4507593] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Active | | BioAssay | uHTS for the identification of compounds that potentiate TRAIL-induced apoptosis of cancer cells | | AID | 1443 | | BioAssay type | screening | | Target | tumor necrosis factor ligand superfamily member 10 isoform 1 [Homo sapiens] [gi:4507593] | | PubMed | | | Data Table |  |
|
| 45 | [SID26660322] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 46 | [SID26660322] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 47 | [SID26660322] | Unspecified | | | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay [AID651596_2, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Unspecified | | BioAssay | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay | | AID | 651596 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 48 | [SID26660322] | Unspecified | | | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay [AID651596_2, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Unspecified | | BioAssay | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay | | AID | 651596 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 49 | [SID26660322] | Unspecified | | | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay [AID651596_3, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Unspecified | | BioAssay | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay | | AID | 651596 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 50 | [SID26660322] | Unspecified | | | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay [AID651596_3, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 26660322 | | CID | 16682074 | | Outcome | Unspecified | | BioAssay | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay | | AID | 651596 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|